Australia Markets closed

Living Cell Technologies Limited (LVCLF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.00430.0000 (0.00%)
At close: 10:44AM EDT

Living Cell Technologies Limited

Tower 2
Level 16 Darling Park 201 Sussex Street
Sydney, NSW 2000
Australia
61 3 8689 9997
https://www.lctglobal.com

Sector(s):Β Healthcare
Industry:Β Biotechnology
Full-time employees:Β 

Key executives

NameTitlePayExercisedYear born
Dr. Bernard Tuch BSc, FRACP, GAICD, MBBS (Hons), Ph.D.Exec. Chairman & Interim CEO47.1kN/A1951
Mr. Daya UkaChief Financial Officer105.62kN/AN/A
Dr. Belinda Di BartoloChief Operating OfficerN/AN/AN/A
Mr. Mark Andrew Licciardo B Bus (Acc), FCIS, FGIA, GAICD, GradDip CSPCompany Sec.N/AN/A1964
Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Living Cell Technologies Limited, a biotechnology company, discovers, develops, and commercializes regenerative treatments that use naturally occurring cells to restore functions in New Zealand. It is developing NTCELL, an alginate-coated capsule, which is in phase IIb clinical trial for the treatment of Parkinson's disease. The company was founded in 1987 and is based in Sydney, Australia.

Corporate governance

Living Cell Technologies Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.